Pepteca

Recovery & repair

BPC-157

Body Protection Compound 157 · Bepecin · PL 14736 · 15-aa · gastric

A synthetic fragment discussed in the community for soft-tissue repair — animal studies only so far, human evidence limited.

Reference status

Editorial research · independent review pending · 4 claims graded

Editorial researchResearch-onlyPreclinical · animal only78% positive discussion

What it is

BPC-157 is a synthetic peptide of 15 amino acids, derived from a protein found in human gastric juice. It is one of the most talked-about peptides online, usually in the context of tendon, ligament, muscle and gut healing.

It is important to separate what has been shown from what is claimed. Almost all of the promising data on BPC-157 comes from rodent studies. There are, as of writing, no large published human randomised controlled trials establishing safety or efficacy for the repair uses it is marketed for.

The science, graded

What’s claimed — and how strong the evidence behind each claim actually is.

“Accelerates tendon and ligament healing”

Consistent, striking effects in rat models. No controlled human trials confirm this yet.

Claim-level citation mapping is in progress.

preclinical
Preclinical · animal only

“Repairs gut lining / helps IBD & leaky gut”

Animal models of colitis show benefit. Human gut-repair claims are extrapolation, not proven.

Claim-level citation mapping is in progress.

preclinical
Preclinical · animal only

“Protects against NSAID and alcohol damage”

Demonstrated in rodents; no human safety/efficacy data.

Claim-level citation mapping is in progress.

preclinical
Preclinical · animal only

“Well tolerated with no side effects”

Community reports are largely positive, but long-term human safety has not been formally studied.

Claim-level citation mapping is in progress.

anecdotal
Anecdotal · community

Legal and regulatory context

Separate summaries for Great Britain, the United States, and the European Union. These are preliminary research summaries awaiting independent regional review; they are not legal determinations or advice.

Great Britain

Preliminary researchResearch-only

In the UK, BPC-157 is not a licensed medicine and is not an approved cosmetic ingredient. It sits in a research-only context — products are typically sold labelled 'for research use, not for human consumption'. There is no legal route to sell it as a supplement or medicine for human use.

This is preliminary regulatory research, not a reviewed legal determination or legal advice.

United States

Preliminary researchReview pending

Regional legal and regulatory review required before publication.

This is preliminary regulatory research, not a reviewed legal determination or legal advice.

European Union

Preliminary researchReview pending

Regional legal and regulatory review required before publication.

This is preliminary regulatory research, not a reviewed legal determination or legal advice.

What the community says

One of the most enthusiastically discussed peptides on Reddit and biohacking forums, especially for injuries the medical system is slow to fix. Sceptics repeatedly point out the animal-only evidence base and sourcing risk.

Share of positive discussion78%

Where they’re talking

  • r/PeptidesFrequent 'healed my tendon' anecdotes; heavy dosing debate.
  • r/AdvancedFitnessMore cautious; asks for human data before recommending.

Appears in these stacks

Wolverine

Soft-tissue & injury recovery

The internet's most-named recovery stack: BPC-157 paired with TB-500 for tendon, ligament and muscle repair. Both are preclinical-only in humans and research-only in the UK.

GLOW

Skin quality & appearance

A skin-focused stack built around GHK-Cu, the one peptide here with a real cosmetic evidence base — sometimes combined with recovery peptides.

KLOW

Skin, gut & inflammation

An extended GLOW variant that adds KPV, discussed for its anti-inflammatory profile. Evidence across the components is mixed to preclinical.

References

  1. 1.Supply unlicensed medicinal products (specials) · MHRA
  2. 2.FDA's Concerns About Unapproved Drugs · U.S. Food and Drug Administration
  3. 3.Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks · U.S. Food and Drug Administration
  4. 4.Buying medicines online · European Medicines Agency
Educational, not advice or endorsement. Educational reference only. Independent review is pending. Do not use this entry to make medical, purchasing, dosing, or treatment decisions.This editorial research entry preserves the existing material but has not yet passed independent scientific and regional regulatory review.